Politics

Pediatric group splits from CDC over curtailed vaccine recommendations

Illustration for: Pediatric group splits from CDC over curtailed vaccine recommendations
AI-generated illustration. Visual interpretation does not represent real individuals or scenes.

Jan 27, 2026

THE BARE STORY

The American Academy of Pediatrics (AAP) issued new childhood immunization guidelines on Monday that diverge significantly from recent recommendations released by the Centers for Disease Control and Prevention (CDC). While the AAP continues to advise vaccination against 18 diseases, the CDC recently narrowed its universal recommendations to 11. Both organizations maintain alignment on core inoculations, including those for polio, measles, mumps, and rubella.

Under the Trump administration, federal health agencies have shifted several vaccinations—including those for influenza, COVID-19, hepatitis A, and hepatitis B—to a "shared clinical decision-making" model or restricted them to high-risk groups. Consequently, the CDC now recommends vaccines for RSV and meningococcal disease only for children in high-risk categories. Department of Health and Human Services (HHS) officials stated that the updated schedule restores "informed consent" and aligns U.S. guidance with international norms. HHS Secretary Robert F. Kennedy Jr. emphasized that vaccines remain available and covered by insurance, though he noted that obtaining a flu shot now requires a physician consultation.

The AAP characterized the CDC’s revised guidance as "dangerous and unnecessary," asserting that the changes depart from established medical evidence. Conversely, Secretary Kennedy—who appointed the advisory panel that recommended delaying the first hepatitis B dose for infants—has expressed skepticism regarding widespread vaccination. He has claimed, without citing evidence, that the COVID-19 vaccine is the "deadliest ever made" and suggested that lower flu vaccination rates might be beneficial.

These policy shifts coincide with the administration halting approximately $500 million in funding for mRNA-based vaccines and cancelling Biden-era development contracts. The changes come despite ongoing research highlighting the long-term impacts of COVID-19, which studies suggest can include cognitive deficits, heart irregularities, and increased risks for developmental delays in children exposed in utero. Researchers have expressed concern that the new policies may hinder efforts to address these long-term health risks.

Same Facts. Different Perspectives.

Two AI models. Two viewpoints. One factual foundation.

Perspective by Claude

• Adherence to broad vaccination guidelines The American Academy of Pediatrics (AAP) has maintained recommendations for vaccination against 18 diseases, characterizing the CDC's decision to narrow universal guidance to 11 as "dangerous and unnecessary." The organization asserts that these federal changes represent a departure from established medical evidence regarding childhood immunization.

• Concerns regarding long-term health risks Researchers have highlighted ongoing studies that link COVID-19 to long-term impacts such as cognitive deficits, heart irregularities, and developmental delays in children exposed in utero. There is expressed concern within the research community that the administration's new policies may hinder necessary efforts to address these persistent health risks.

• Skepticism of administrative claims and cuts Critics note that HHS Secretary Robert F. Kennedy Jr. has made allegations regarding the safety of the COVID-19 vaccine without citing evidence. Furthermore, the divergence in policy coincides with the cancellation of development contracts and a halt to approximately $500 million in funding for mRNA-based vaccines.

How it may affect me

As a U.S. reader: Parents navigating healthcare may receive conflicting advice, as pediatricians continue recommending 18 universal vaccines while federal guidelines have narrowed universal recommendations to 11.

Obtaining flu, COVID-19, and hepatitis shots will change procedurally, now requiring a physician consultation for "shared clinical decision-making" rather than automatic administration.

While vaccines remain covered by insurance, access to RSV and meningococcal immunizations is now restricted specifically to children categorized as high-risk.

The suspension of $500 million in funding for mRNA research and cancelled contracts could affect the long-term development and availability of future vaccine technologies.

Read the story at

Note: All TheBareNews content is AI-generated. For additional context, reporting, and updates, you are invited to explore the news outlets linked above.